Shigeo Toyota

Yokosuka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Comparison of Pola-R-CHP and R-CHOP for newly diagnosed DLBCL: A single-center retrospective study.

Comparison of Pola-R-CHP and R-CHOP for newly diagnosed DLBCL: A single-center retrospective study.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: July 30, 2026

Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.

Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.

Journal: British journal of haematology

Published: February 21, 2026

Reduced-Dose Bendamustine as a First-Line Treatment of Follicular Lymphoma Is Associated With Poorer Prognosis.

Reduced-Dose Bendamustine as a First-Line Treatment of Follicular Lymphoma Is Associated With Poorer Prognosis.

Journal: Cancer medicine

Published: October 08, 2025

Efficacy and safety of venetoclax-based regimens versus intensive chemotherapy in older adults with newly diagnosed acute myeloid leukemia: a single-center retrospective study.

Efficacy and safety of venetoclax-based regimens versus intensive chemotherapy in older adults with newly diagnosed acute myeloid leukemia: a single-center retrospective study.

Journal: International journal of hematology

Published: August 09, 2025

Successful Control of Chemotherapy-Induced Breakthrough Hemolysis With Ravulizumab in a Patient With Paroxysmal Nocturnal Hemoglobinuria During Carboplatin-Pemetrexed Treatment for Lung Adenocarcinoma.

Successful Control of Chemotherapy-Induced Breakthrough Hemolysis With Ravulizumab in a Patient With Paroxysmal Nocturnal Hemoglobinuria During Carboplatin-Pemetrexed Treatment for Lung Adenocarcinoma.

Journal: Cureus

Published: July 18, 2025

Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group.

Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group.

Journal: International journal of hematology

Published: July 14, 2025

Investigation of early mortality in the patients with newly diagnosed multiple myeloma: insights from a real-world cohort using J-CHAEGE-MM database.

Investigation of early mortality in the patients with newly diagnosed multiple myeloma: insights from a real-world cohort using J-CHAEGE-MM database.

Journal: International journal of hematology

Published: June 06, 2025

Long-term remission in a patient with NK/T cell intravascular lymphoma with autologous hematopoietic cell transplantation.

Long-term remission in a patient with NK/T cell intravascular lymphoma with autologous hematopoietic cell transplantation.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 30, 2025

Utility of CSF IL-6 monitoring in managing ICANS associated with Epcoritamab treatment: a case report and literature review.

Utility of CSF IL-6 monitoring in managing ICANS associated with Epcoritamab treatment: a case report and literature review.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 30, 2025

Cytomegalovirus Retinitis Following Daratumumab for Multiple Myeloma: A Case Report and Literature Review.

Cytomegalovirus Retinitis Following Daratumumab for Multiple Myeloma: A Case Report and Literature Review.

Journal: Case reports in medicine

Published: January 17, 2025

First reported case of disseminated Cunninghamella phaeospora infection with multidrug resistance in acute myeloid leukemia.

First reported case of disseminated Cunninghamella phaeospora infection with multidrug resistance in acute myeloid leukemia.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: December 27, 2024

A phase 2 trial of VRD induction for transplant-eligible Japanese patients with newly diagnosed multiple myeloma.

A phase 2 trial of VRD induction for transplant-eligible Japanese patients with newly diagnosed multiple myeloma.

Journal: International journal of hematology

Published: November 28, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026